4//SEC Filing
Raskin Gregory S 4
Accession 0000921895-19-002358
CIK 0001722964other
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 8:05 PM ET
Size
5.3 KB
Accession
0000921895-19-002358
Insider Transaction Report
Form 4
Raskin Gregory S
Director
Transactions
- Sale
Common Stock
2019-08-29$26.70/sh−5,882$157,026→ 0 total
Footnotes (2)
- [F1]The Reporting Person has entered into a contract with Memorial Sloan Kettering Cancer Center pursuant to which the Reporting Person will contribute to Memorial Sloan Kettering Cancer Center his earnings from the interests described herein.
- [F2]This transaction was executed in multiple trades. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Y-mAbs Therapeutics, Inc.
CIK 0001722964
Entity typeother
Related Parties
1- filerCIK 0001753646
Filing Metadata
- Form type
- 4
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 8:05 PM ET
- Size
- 5.3 KB